AMOXICILLIN CAPSULE

País: Canadá

Idioma: inglés

Fuente: Health Canada

Ingredientes activos:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE)

Disponible desde:

SANIS HEALTH INC

Código ATC:

J01CA04

Designación común internacional (DCI):

AMOXICILLIN

Dosis:

500MG

formulario farmacéutico:

CAPSULE

Composición:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 500MG

Vía de administración:

ORAL

Unidades en paquete:

100/500

tipo de receta:

Prescription

Área terapéutica:

AMINOPENICILLINS

Resumen del producto:

Active ingredient group (AIG) number: 0131314006; AHFS:

Estado de Autorización:

APPROVED

Fecha de autorización:

2010-11-02

Ficha técnica

AMOXICILLIN
1
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR AMOXICILLIN
AMOXICILLIN CAPSULES, USP
Capsules, 250 mg and 500 mg amoxicillin (as amoxicillin trihydrate),
Oral
AMOXICILLIN GRANULES FOR ORAL SUSPENSION, USP
Suspension, 250 mg/5 mL amoxicillin (as amoxicillin trihydrate) after
reconstitution, Oral
AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION,
Manufacturer’s Standard
Suspension, 250 mg/5 mL amoxicillin (as amoxicillin trihydrate) after
reconstitution, Oral
Antibiotic
Sanis Health Inc.
Date of Initial Authorization:
1 President’s Choice Circle
JUN 16, 2010
Brampton, Ontario
L6Y 5S5
Date of Revision:
www.sanis.com
AUG 14, 2023
Submission Control Number: 277120
AMOXICILLIN
2
RECENT MAJOR LABEL CHANGES
3 SERIOUS WARNINGS AND PRECAUTIONS BOX
08/2023
7 WARNINGS AND PRECAUTIONS
08/2023
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.....................................................................
4
1
INDICATIONS
..................................................................................................................
4
1.1
Pediatrics
......................................................................................................................
4
1.2
Geriatrics
.......................................................................................................................
4
2
CONTRAINDICATIONS
.....................................................................................................
4
3
SERIOUS WARNINGS AND PRECAUTIONS BOX
................................................................ 5
4
DOSAGE AND ADMINISTRATION
.....................................................................................
5
4.1
Dosing Considerations
..................................................................................................
5
4.2
Recommended Dose and Dosage Adjustment
.............................................................. 5
4.3
Reconstitution
.....................................................................................